BEMCENTINIB clinical trials

Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct)

This study is testing a new medicine called bemcentinib for people with moderate COVID-19. It aims to see if the medicine can help them get better faster and prevent them from becoming more unwell. Researchers will also check if the medicine is safe to use.